Instituto: INSTITUTO DE INVESTIGACIÓN BIOMÉDICA DE SALAMANCA

Doutor pola Universidad de Salamanca coa tese Inhibition of shp1 and shp2 as a molecular targeted therapy against myeloid leukaemias 2019. Dirixida por Dr. Ángel Hernández Hernández.